These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16407047)

  • 1. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
    Kavanagh JP; Laube N
    J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas.
    Laube N; Hergarten S; Hoppe B; Schmidt M; Hesse A
    J Urol; 2004 Jul; 172(1):355-9. PubMed ID: 15201810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can the Bonn Risk Index be replaced by a simple measurement of the urinary concentration of free calcium ions?
    Laube N; Hergarten S
    J Urol; 2005 Jun; 173(6):2175-7. PubMed ID: 15879882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring of the treatment of calcium-oxalate stone formers with the Bonn-Risk-Index].
    Laube N; Schmidt M; Hesse A
    Urologe A; 2003 Feb; 42(2):243-9. PubMed ID: 12607094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical studies of the recurrence of urolithiasis (4). Crystal formation in urine and stone recurrence].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1988 Sep; 34(9):1543-7. PubMed ID: 3213790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK; Sutton RA
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normative data on the Bonn Risk Index for calcium oxalate crystallization in healthy children.
    Porowski T; Zoch-Zwierz W; Wasilewska A; Spotyk A; Konstantynowicz J
    Pediatr Nephrol; 2007 Apr; 22(4):514-20. PubMed ID: 17216257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bonn Risk Index based micromethod for assessing risk of urinary calcium oxalate stone formation.
    Porowski T; Mrozek P; Sidun J; Zoch-Zwierz W; Konstantynowicz J; Kirejczyk JK; Motkowski R; Laube N
    J Urol; 2010 Mar; 183(3):1157-62. PubMed ID: 20096860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal oxalate excretion following oral oxalate load in patients with urinary calculus disease and healthy controls].
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Okawa T
    Hinyokika Kiyo; 1986 Dec; 32(12):1773-9. PubMed ID: 3825824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inositol hexaphosphate (phytate) on calcium binding, calcium oxalate crystallization and in vitro stone growth.
    Saw NK; Chow K; Rao PN; Kavanagh JP
    J Urol; 2007 Jun; 177(6):2366-70. PubMed ID: 17509360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?
    Osther PJ
    Scand J Urol Nephrol; 1999 Dec; 33(6):368-71. PubMed ID: 10636575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA; Hennequin C; Lacour B; Daudon M
    Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new approach to the diagnosis of children's urolithiasis based on the Bonn Risk Index.
    Porowski T; Zoch-Zwierz W; Konstantynowicz J; Taranta-Janusz K
    Pediatr Nephrol; 2008 Jul; 23(7):1123-8. PubMed ID: 18335253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Calcium concentrations in the urine of recurrent stone-formers and their controls (author's transl)].
    Leskovar P; Hartung R; Siebert A; Wellnhofer E
    Urologe A; 1980 Jul; 19(4):207-13. PubMed ID: 7414765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ; Kinder JM; Asplin JR; Coe BJ; Coe FL
    J Urol; 2002 Jun; 167(6):2372-6. PubMed ID: 11992040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophoretic separation and characterization of urinary glycosaminoglycans and their roles in urolithiasis.
    Gohel MD; Shum DK; Tam PC
    Carbohydr Res; 2007 Jan; 342(1):79-86. PubMed ID: 17145044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.